Riskpilot← Back to searchSign inGet full accessDeversify AB
ABBankruptOrg 5590676788Research and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2023
SEK 2,8M
+16% vs 2022
EBITDA margin
-248.4%
+46% vs 2022
Equity ratio
-79.0%
Financial strength
Net profit 2023
SEK -9,7M
+36% vs 2022
| Revenue | SEK 2,8M | +16% |
| EBITDA | SEK -6,9M | +46% |
| Net profit | SEK -9,7M | +36% |
| Total assets | SEK 11,4M | -27% |
| Equity | SEK -9M | -2179% |
| Employees | 0 | — |
Legal name
Deversify AB
Org number
5590676788
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 juni 2016
Share capital
SEK 283 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Deversify AB är ett utvecklingsbolag som tar fram produkter, i form av instrument och därtill hörande mjukvara, för mobil hälsa (m-health), åt olika marknadsbolag verksamma i Norden likväl som övriga världen, för olika användningsområden, i första hand medicinteknik men även konsumentteknik.
Address
Email
anders.murman@deversify.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 68 | 238 | 136 | 719 | 2 372 | 2 761 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −362 | −2 096 | −1 819 | −829 | −2 850 | −10 040 | −12 782 | −6 859 |
| Depreciation & amort. | −0 | −0 | −14 | −542 | −1 124 | −1 324 | −1 762 | −1 726 |
| EBIT | −362 | −2 096 | −1 833 | −1 371 | −3 974 | −11 364 | −14 544 | −8 585 |
| Net financials | −29 | −67 | −145 | −168 | −160 | −291 | −581 | −1 141 |
| Profit before tax | −391 | −2 163 | −1 978 | −1 539 | −4 134 | −11 656 | −15 125 | −9 714 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −391 | −2 163 | −1 978 | −1 539 | −4 134 | −11 656 | −15 125 | −9 714 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 1 933 | 4 421 | 5 838 | 5 204 | 5 417 | 11 661 | 15 549 | 11 386 |
| Equity | 1 433 | 194 | 816 | 1 997 | 235 | −2 194 | 433 | −9 000 |
| Long-term debt | 500 | 2 500 | 2 365 | 2 197 | 3 550 | 4 671 | 8 117 | 12 303 |
| Short-term debt | 0 | 1 727 | 2 657 | 1 010 | 1 632 | 9 184 | 7 000 | 8 083 |
| Total debt | 500 | 4 227 | 5 022 | 3 207 | 5 182 | 13 855 | 15 117 | 20 386 |
EBITDA margin
-248.4%
This company
15.8%
Market median
-1672% vs market
20162023
Equity ratio
-79.0%
This company
38.2%
Market median
-307% vs market
20162023
Return on equity
-971400000.0%
This company
18.4%
Market median
-5279347926% vs market
20162023
Net profit margin
-351.8%
This company
8.1%
Market median
-4443% vs market
20162023
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20162023
Debt / equity
2.27×
This company
0.62×
Market median
-266% vs market
20162023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-06-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Chief Auditor | Chief Auditor | 2021 | — | — |
JL Chief Auditor | Chief Auditor | 2024 | — | — |
LG Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Chairman | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Deversify AB 
Aspirable Technologies ABBoard members of Deversify AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tabitha Michelle Hayes | Chief Auditor | 0 companies |
| Joakim Lindberg | Chief Auditor | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Nils-Olof Martin Engberg | Board of Directors | 0 companies |
| Åsa Victoria Lang | Board of Directors | 0 companies |
| Madelen Ulrika Margaretha Lagin | Board of Directors | 0 companies |
| Karl Emil Andreas Murman | Deputy Board Member | 0 companies |
| Carl Johan Wilhelm Willdeck | Deputy Board Member | 0 companies |
| Anders Svante Murman | Chairman | 0 companies |